Warning For Facebook “Likes” Reflects FDA Social Media Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is revealing its views on social media use through individual enforcement actions and provisions in disparate guidances, in the absence of issuing an overarching guidance. A recent warning letter sheds light on the agency’s view of “liking” something on Facebook.
You may also be interested in...
GMP Inspectors Will Scrutinize Adverse Event Reporting Compliance
Regular under-reporting of serious adverse event reports has spurred FDA to have its good manufacturing practice inspectors review dietary supplement firms’ AERs and reporting practices, FDA’s Fabricant says. Key compliance issues can tip off the agency that a company may be falling short on reporting.
Updated FTC Dot Com Disclosures Guide Will Address Twitter, Blogs
The Federal Trade Commission soon will issue updated guidance about how endorsers and marketers should disclose financial relationships on blogs, Twitter and other social media platforms. The original guidance issued in 2000 was published before social networking boomed.
Off-Label Questions, Online: FDA Explains How To Handle Them
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.